Stoke Therapeutics, Inc.
Stoke Therapeutics, Inc.（STOK）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · STOK · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
85
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Stoke Therapeutics, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
STOK 季度内部人买卖趋势
STOK 内幕交易卖出 · STOK 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · STOK CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
STOK 高管卖出股份 · STOK 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 1, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 1,795 | $55K | Form 4 |
| May 1, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 2,243 | $74K | Form 4 |
| Apr 1, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 1,838 | $60K | Form 4 |
| Mar 20, 2026 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 8,692 | $292K | Form 4 |
| Mar 20, 2026 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 601 | $21K | Form 4 |
| Mar 17, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 3,577 | $117K | Form 4 |
| Mar 17, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 2,587 | $86K | Form 4 |
| Mar 19, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Option | 1,365 | $3K | Form 4 |
| Mar 18, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 6,100 | $191K | Form 4 |
| Mar 18, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 483 | $15K | Form 4 |
| Mar 18, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 103 | $3K | Form 4 |
| Mar 19, 2026 | Ticho Barry CHIEF MEDICAL OFFICER | Sale | 1,461 | $44K | Form 4 |
| Mar 17, 2026 | Leggett Thomas CFO | Sale | 1,274 | $42K | Form 4 |
| Mar 17, 2026 | Leggett Thomas CFO | Sale | 922 | $31K | Form 4 |
| Mar 18, 2026 | Leggett Thomas CFO | Sale | 2,173 | $68K | Form 4 |
| Mar 18, 2026 | Leggett Thomas CFO | Sale | 172 | $5K | Form 4 |
| Mar 18, 2026 | Leggett Thomas CFO | Sale | 37 | $1K | Form 4 |
| Mar 17, 2026 | Hoitt Jason Chief Patient Officer | Sale | 1,033 | $34K | Form 4 |
| Mar 17, 2026 | Hoitt Jason Chief Patient Officer | Sale | 748 | $25K | Form 4 |
| Mar 18, 2026 | Hoitt Jason Chief Patient Officer | Sale | 1,762 | $55K | Form 4 |
| Mar 18, 2026 | Hoitt Jason Chief Patient Officer | Sale | 139 | $4K | Form 4 |
| Mar 18, 2026 | Hoitt Jason Chief Patient Officer | Sale | 30 | $986 | Form 4 |
| Mar 17, 2026 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 2,476 | $81K | Form 4 |
| Mar 17, 2026 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 1,791 | $60K | Form 4 |
| Mar 18, 2026 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Sale | 4,222 | $132K | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 STOK 内幕交易
STOK 内幕交易
Stoke Therapeutics, Inc.（STOK）内幕交易数据来源于公司内部人（包括Ticho Barry (CHIEF MEDICAL OFFICER), Allan Jonathan (GENERAL COUNSEL & CORP SEC), Kaye Edward M. MD (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。STOK内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Stoke Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
STOK 内幕交易 · 5个问题Stoke Therapeutics, Inc.（STOK）的内部人包括高管和董事，如Ticho Barry (CHIEF MEDICAL OFFICER), Allan Jonathan (GENERAL COUNSEL & CORP SEC), Kaye Edward M. MD (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026